Cargando…

Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles

Indolylarylsulfones (IASs) are classical HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) with a unique scaffold and possess potent antiviral activity. To address the high cytotoxicity and improve safety profiles of IASs, we introduced various sulfonamide groups linked by alkyl diamine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Shenghua, Song, Letian, Cheng, Yusen, Zhao, Fabao, Kang, Dongwei, Song, Shu, Yang, Mianling, Ye, Bing, Zhao, Wei, Tang, Yajie, De Clercq, Erik, Pannecouque, Christophe, Zhan, Peng, Liu, Xinyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326263/ https://www.ncbi.nlm.nih.gov/pubmed/37425059 http://dx.doi.org/10.1016/j.apsb.2023.01.003

Ejemplares similares

Identification of Novel Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors by Exploring the Primer Grip Region
por: Zhang, Tao, et al.
Publicado: (2022)

Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIs
por: Kang, Dongwei, et al.
Publicado: (2020)

Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitors
por: Jiang, Xiangyi, et al.
Publicado: (2023)

Covalently Targeted Highly Conserved Tyr318 to Improve the Drug Resistance Profiles of HIV-1 NNRTIs: A Proof-of-Concept Study
por: Zhou, Zhenzhen, et al.
Publicado: (2023)

Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors
por: Gao, Shenghua, et al.
Publicado: (2022)

Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors
por: Famiglini, Valeria, et al.
Publicado: (2018)

Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors
por: Gao, Shenghua, et al.
Publicado: (2022)

Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid Modulators
por: Xu, Shujing, et al.
Publicado: (2022)

Structural basis for potent and broad inhibition of HIV-1 RT by thiophene[3,2-d]pyrimidine non-nucleoside inhibitors
por: Yang, Yang, et al.
Publicado: (2018)

Discovery of cyclic sulfonamide derivatives as potent inhibitors of SARS-CoV-2
por: Shin, Young Sup, et al.
Publicado: (2021)

Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
por: Feng, Da, et al.
Publicado: (2022)

Development of fluorine-substituted NH(2)-biphenyl-diarylpyrimidines as highly potent non-nucleoside reverse transcriptase inhibitors: Boosting the safety and metabolic stability
por: Jin, Xin, et al.
Publicado: (2023)

A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation
por: Zhang, Jiwei, et al.
Publicado: (2023)

Synthesis, Antiviral and Cytotoxicity Studies of Novel N-substituted Indophenazine Derivatives
por: Selvam, P., et al.
Publicado: (2012)

Structure-based design of novel heterocycle-substituted ATDP analogs as non-nucleoside reverse transcriptase inhibitors with improved selectivity and solubility
por: Zhao, Li-Min, et al.
Publicado: (2023)

Discovery of the fourth mobile sulfonamide resistance gene
por: Razavi, Mohammad, et al.
Publicado: (2017)

Design, Synthesis and Structure—Activity Relationships of Phenylalanine-Containing Peptidomimetics as Novel HIV-1 Capsid Binders Based on Ugi Four-Component Reaction
por: Ji, Xiangkai, et al.
Publicado: (2022)

Theoretical Study on the Alkylimino-Substituted Sulfonamides with Potential Biological Activity
por: Brzeski, Jakub, et al.
Publicado: (2023)

Substituted imidazopyridines as potent inhibitors of HCV replication()
por: Vliegen, Inge, et al.
Publicado: (2009)

First discovery of novel 3-hydroxy-quinazoline-2,4(1H,3H)-diones as specific anti-vaccinia and adenovirus agents via ‘privileged scaffold’ refining approach
por: Kang, Dongwei, et al.
Publicado: (2016)

Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary
por: Xu, Shujing, et al.
Publicado: (2022)

Novel Sulfonamide Analogs of Sivelestat as Potent Human Neutrophil Elastase Inhibitors
por: Crocetti, Letizia, et al.
Publicado: (2020)

SMIP-30, a potent and selective PPM1A inhibitor with potential to treat tuberculosis
por: Xu, Shujing, et al.
Publicado: (2022)

Correction to “Theoretical Study on the Alkylamino-Substituted Sulfonamides with Potential Biological Activity”
por: Brzeski, Jakub, et al.
Publicado: (2023)

Structure-Based Discovery and Characterization of a Preclinical Drug Candidate for the Treatment of HIV-1 Infection
por: Kang, Dongwei, et al.
Publicado: (2022)

Design of Biphenyl-Substituted Diarylpyrimidines with a Cyanomethyl Linker as HIV-1 NNRTIs via a Molecular Hybridization Strategy
por: Lei, Yuan, et al.
Publicado: (2020)

Improving the positional adaptability: structure-based design of biphenyl-substituted diaryltriazines as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
por: Jin, Kaijun, et al.
Publicado: (2020)

The development of an effective synthetic route of lesinurad (RDEA594)
por: Meng, Qing, et al.
Publicado: (2017)

Development of a practical synthesis of etravirine via a microwave-promoted amination
por: Feng, Da, et al.
Publicado: (2018)

Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid Modulators
por: Zhang, Xujie, et al.
Publicado: (2022)

The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivity
por: Newton, Rebecca, et al.
Publicado: (2016)

Discovery of Novel N-Substituted Prolinamido Indazoles as Potent Rho Kinase Inhibitors and Vasorelaxation Agents
por: Yao, Yangyang, et al.
Publicado: (2017)

Scaffold Hopping in Discovery of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: From CH(CN)-DABOs to CH(CN)-DAPYs
por: Li, Ting-Ting, et al.
Publicado: (2020)

4-[1-(Substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulfonic acids: Synthesis, antimicrobial activity, QSAR studies, and antiviral evaluation
por: Yadav, Snehlata, et al.
Publicado: (2010)

Synthesis of an acridine orange sulfonamide derivative with potent carbonic anhydrase IX inhibitory action
por: Bragagni, Marco, et al.
Publicado: (2017)

Discovery of N-(2-Amino-4-Fluorophenyl)-4-[bis-(2-Chloroethyl)-Amino]-Benzamide as a Potent HDAC3 Inhibitor
por: Chen, Yiming, et al.
Publicado: (2020)

Discovery of Metal Ions Chelator Quercetin Derivatives with Potent Anti-HCV Activities
por: Zhong, Dongwei, et al.
Publicado: (2015)

Design, synthesis, and molecular docking studies of N-substituted sulfonamides as potential anticancer therapeutics
por: Babalola, Ibrahim T., et al.
Publicado: (2023)

Discovery of aryl sulfonamide-selective Nav1.7 inhibitors with a highly hydrophobic ethanoanthracene core
por: Wang, Jin-tao, et al.
Publicado: (2019)

Recent developments in the medicinal chemistry of single boron atom-containing compounds
por: Song, Shu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hcffe0umgrtq2095vkqsbce0g3